Brain angiotensin II and angiotensin IV receptors as potential Alzheimer’s disease therapeutic targets
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Brain angiotensin II and angiotensin IV receptors as potential Alzheimer’s disease therapeutic targets
Authors
Keywords
-
Journal
GeroScience
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-23
DOI
10.1007/s11357-020-00231-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AT2R’s (Angiotensin II Type 2 Receptor’s) Role in Cognitive and Cerebrovascular Deficits in a Mouse Model of Alzheimer Disease
- (2020) Jessika Royea et al. HYPERTENSION
- Midlife Hypertension and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
- (2019) Matthew J. Lennon et al. JOURNAL OF ALZHEIMERS DISEASE
- Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease
- (2019) Jessika Royea et al. NEUROBIOLOGY OF DISEASE
- Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals – A randomized double- blind pre-clinical study
- (2018) Heba A. Ahmed et al. BEHAVIOURAL BRAIN RESEARCH
- Within the Brain: The Renin Angiotensin System
- (2018) LaDonya Jackson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
- (2018) Melanie D. Sweeney et al. Nature Reviews Neurology
- Targeting Renin–Angiotensin System Against Alzheimer’s Disease
- (2018) Abadi Kahsu Gebre et al. Frontiers in Pharmacology
- Angiotensin IV suppresses inflammation in the brains of rats with chronic cerebral hypoperfusion
- (2018) Qing-Guang Wang et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease
- (2018) Lianne J. Trigiani et al. HYPERTENSION
- Angiotensin receptor (AT2R) agonist C21 prevents cognitive decline after permanent stroke in aged animals—A randomized double- blind pre-clinical study
- (2018) Heba A. Ahmed et al. BEHAVIOURAL BRAIN RESEARCH
- Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease
- (2017) Jessika Royea et al. JOURNAL OF NEUROSCIENCE
- Angiotensin Mediated Oxidative Stress and Neuroprotective Potential of Antioxidants and AT1 Receptor Blockers
- (2017) Shakti Prusty et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-κB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats
- (2017) Ruby Goel et al. MOLECULAR NEUROBIOLOGY
- Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
- (2017) Kassandra Kisler et al. NATURE REVIEWS NEUROSCIENCE
- Angiotensin-(1–7) administration attenuates Alzheimer’s disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation
- (2017) Jin-Liang Chen et al. NEUROSCIENCE
- Role of Improved Vascular Health in the Declining Incidence of Dementia
- (2017) Matthew P. Pase et al. STROKE
- Memory is preserved in older adults taking AT1 receptor blockers
- (2017) Jean K. Ho et al. Alzheimers Research & Therapy
- Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration
- (2017) Jose L. Labandeira-Garcia et al. Frontiers in Aging Neuroscience
- The Cellular Phase of Alzheimer’s Disease
- (2016) Bart De Strooper et al. CELL
- Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient population
- (2016) K Rygiel Journal of Postgraduate Medicine
- Angiotensin IV protects cardiac reperfusion injury by inhibiting apoptosis and inflammation via AT4R in rats
- (2016) Byung Mun Park et al. PEPTIDES
- Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
- (2016) Y. Iturria-Medina et al. Nature Communications
- Compound 21, a selective agonist of angiotensin AT2receptors, prevents endothelial inflammation and leukocyte adhesionin vitroandin vivo
- (2015) Amanda K Sampson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment
- (2015) Michel J. Grothe et al. CEREBRAL CORTEX
- New cardiovascular targets to prevent late onset Alzheimer disease
- (2015) Jurgen A.H.R. Claassen EUROPEAN JOURNAL OF PHARMACOLOGY
- AT2 Receptor Activities and Pathophysiological Implications
- (2015) Luis C. Matavelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer’s Disease
- (2015) Teng Jiang et al. MOLECULAR NEUROBIOLOGY
- Immunotherapeutic Approaches for Alzheimer’s Disease
- (2015) Thomas Wisniewski et al. NEURON
- Angiotensin AT2 receptor stimulation inhibits activation of NADPH oxidase and ameliorates oxidative stress in rotenone model of Parkinson's disease in CATH.a cells
- (2015) Jie Lu et al. NEUROTOXICOLOGY AND TERATOLOGY
- The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases
- (2015) John W. Wright et al. PROGRESS IN NEUROBIOLOGY
- Relative affinity of angiotensin peptides and novel ligands at AT1and AT2receptors
- (2015) Sanja Bosnyak et al. CLINICAL SCIENCE
- Neuroprotective Effects of Angiotensin Receptor Blockers
- (2014) Sonia Villapol et al. AMERICAN JOURNAL OF HYPERTENSION
- Vascular risk factors and Alzheimer’s disease
- (2014) John T O’Brien et al. BMC Medicine
- Angiotensin-(1-7) improves cognitive function in rats with chronic cerebral hypoperfusion
- (2014) Wei Xie et al. BRAIN RESEARCH
- Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway
- (2014) Teng Jiang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice
- (2014) Mohamad Nasser et al. Cardiovascular Diabetology
- Angiotension receptor blockers reduce the risk of dementia
- (2014) Wei-Che Chiu et al. JOURNAL OF HYPERTENSION
- Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow
- (2014) Hongmei Li et al. Molecular Neurodegeneration
- Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model
- (2014) Brice Ongali et al. NEUROBIOLOGY OF DISEASE
- Neuronal over-expression of ACE2 protects brain from ischemia-induced damage
- (2014) Ji Chen et al. NEUROPHARMACOLOGY
- Differential effects of angiotensin II receptor blockers on Aβ generation
- (2014) Junjun Liu et al. NEUROSCIENCE LETTERS
- The Pathobiology of Vascular Dementia
- (2013) Costantino Iadecola NEURON
- Central administration of angiotensin IV rapidly enhances novel object recognition among mice
- (2013) Jason J. Paris et al. NEUROPHARMACOLOGY
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Angiotensin II potentiates zinc-induced cortical neuronal death by acting on angiotensin II type 2 receptor
- (2013) Mi-Ha Park et al. Molecular Brain
- Role of Renin-Angiotensin System in Inflammation, Immunity and Aging
- (2012) Luciano S.A. Capettini et al. CURRENT PHARMACEUTICAL DESIGN
- Angiotensin-(1-7) modulates renin–angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats
- (2012) Teng Jiang et al. PHARMACOLOGICAL RESEARCH
- Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke
- (2011) Adam P. Mecca et al. EXPERIMENTAL PHYSIOLOGY
- Direct Stimulation of Angiotensin II Type 2 Receptor Enhances Spatial Memory
- (2011) Fei Jing et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The projected effect of risk factor reduction on Alzheimer's disease prevalence
- (2011) Deborah E Barnes et al. LANCET NEUROLOGY
- Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
- (2011) J. Li et al. NEUROLOGY
- Brain renin-angiotensin—A new look at an old system
- (2011) John W. Wright et al. PROGRESS IN NEUROBIOLOGY
- Vascular Contributions to Cognitive Impairment and Dementia
- (2011) Philip B. Gorelick et al. STROKE
- Vascular risk factor detection and control may prevent Alzheimer's disease
- (2010) Jack C. de la Torre AGEING RESEARCH REVIEWS
- Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB
- (2010) Franziska Rompe et al. HYPERTENSION
- Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies
- (2010) Craig Anderson et al. LANCET NEUROLOGY
- The Science of Stroke: Mechanisms in Search of Treatments
- (2010) Michael A. Moskowitz et al. NEURON
- Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
- (2010) Lusine Danielyan et al. REJUVENATION RESEARCH
- The role of the AT4 and cholinergic systems in the Nucleus Basalis Magnocellularis (NBM): Effects on spatial memory
- (2009) Wendy L. Wilson et al. BRAIN RESEARCH
- Angiotensin-converting enzyme 2: a new target for neurogenic hypertension
- (2009) Yumei Feng et al. EXPERIMENTAL PHYSIOLOGY
- Cognitive Deficit in Amyloid-β–Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation
- (2009) Kana Tsukuda et al. HYPERTENSION
- Losartan Metabolite EXP3179
- (2009) Gian Paolo Rossi HYPERTENSION
- Angiotensin Receptor Blocker Prevented β-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling
- (2009) Shuko Takeda et al. HYPERTENSION
- Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice
- (2009) Xin-Kang Tong et al. NEUROBIOLOGY OF DISEASE
- Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
- (2009) Jessica B.S. Langbaum et al. NEUROIMAGE
- Telmisartan prevented cognitive decline partly due to PPAR-γ activation
- (2008) Masaki Mogi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor Agonist
- (2008) N. Nicolakakis et al. JOURNAL OF NEUROSCIENCE
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque
- (2007) Abhijit Dandapat et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search